Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

6.6%

176 terminated/withdrawn out of 2680 trials

Success Rate

91.2%

+4.7% vs industry average

Late-Stage Pipeline

9%

245 trials in Phase 3/4

Results Transparency

43%

783 of 1816 completed trials have results

Key Signals

412 recruiting783 with results116 terminated60 withdrawn

Enrollment Performance

Analytics

N/A
1327(61.7%)
Phase 2
367(17.1%)
Phase 1
168(7.8%)
Phase 3
128(5.9%)
Phase 4
117(5.4%)
Early Phase 1
45(2.1%)
2152Total
N/A(1327)
Phase 2(367)
Phase 1(168)
Phase 3(128)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (2680)

Showing 20 of 2680 trials
NCT05273788Phase 1Active Not Recruiting

Thoracic Neuromodulation for Diabetic Gastroparesis

Role: collaborator

NCT07191561Not Yet Recruiting

Hepatic Lipid Metabolism-Alcohol Use Disorder

Role: lead

NCT06991738Phase 1Not Yet Recruiting

177Lu-DOTA-EB-TATE in Adult Patients With Metastatic, Radioactive Iodine Non-Responsive Oncocytic (Hurthle-Cell) Thyroid Cancer

Role: lead

NCT07465341Not ApplicableRecruiting

Michigan Weight Navigation Program (MiWeigh) Study

Role: collaborator

NCT01237093Phase 1Completed

Developing Biomarkers of Dietary Intake

Role: lead

NCT06690294Not Yet Recruiting

Assessing the Impact of Perceptions of Unpredictability on Objective Measures of Food Consumption and Metabolism

Role: lead

NCT07388537Not Yet Recruiting

Evaluation of the Clinical Spectrum of Diabetes and Obesity in Youth and Adults

Role: lead

NCT07637656Not Yet Recruiting

Discovering Determinants of Food Intake by Application of Artificial Intelligence to Complex, High-Dimensional Data

Role: lead

NCT04633889Phase 2Active Not Recruiting

Deferoxamine for the Prevention of Cardiac Surgery-Associated Acute Kidney Injury

Role: collaborator

NCT05722210Not Yet Recruiting

Prevalence and Development of Liver Dysfunction in Hematopoietic Stem Cell Transplant

Role: lead

NCT05748158Not ApplicableRecruiting

A Study to Investigate Why Overweight People Regain Weight After Losing Weight in a Behavioral Weight Loss Program

Role: collaborator

NCT05713799Phase 2Not Yet Recruiting

Trial of the Combination of Alpha-Lipoic Acid and Mirabegron in Women and in Men With Obesity

Role: lead

NCT07313787Phase 2Not Yet Recruiting

Effects of Meal Macronutrients on Postprandial Lipids

Role: lead

NCT07612007Phase 2Not Yet Recruiting

HRX215, A First Generation MKK4 Inhibitor Drug, for the Treatment of Patients With Colorectal Liver Metastasis After Undergoing a Portal Vein Embolization

Role: collaborator

NCT05880914Recruiting

Precision Medicine Approaches to Renal Osteodystrophy

Role: collaborator

NCT00977977Phase 2Recruiting

Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

Role: lead

NCT07646067Not ApplicableNot Yet Recruiting

Closed Loop Glucose Control in a Simulated ICU Setting

Role: collaborator

NCT02019706Phase 2Recruiting

Prospective Evaluation of 68Ga-DOTATATE PET/CT, Octreotide and F-DOPA PET Imaging in Ectopic Cushing Syndrome

Role: lead

NCT06223555Not ApplicableRecruiting

Variability In Mixed Meal Tests: Fixed Versus Adjusted to Energy Needs Caloric Dose

Role: lead

NCT05681559Not ApplicableCompleted

Investigation of Medical Management to Prevent Episodes of Diverticulitis Trial

Role: collaborator